Home›Companies›BioLite

BioLite, Inc.

Updated Oct 29, 2026·Latest SEC filing Mar 3, 2025·Suggest an edit

About BioLite

BioLite is a private company based in Brooklyn, New York. It has reported $4,400,000 raised in two offerings on Form D since July 2024. Its chief executive is Jonathan Cedar.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Feb 18, 2025Mar 3, 2025$4,000,000of $6.0M target2$2.0MDebt, Options, Convertible Promissory Note, and the Equity Securities Issuable upon conversion of such Convertible Promissory Note.Rule 506(b)Form D ↗
Jun 17, 2024Jul 2, 2024$400,000fully sold2$200KEquity, Options, SAFEs, and the Equity Securities Issuable upon conversion of such SAFEsRule 506(b)Form D ↗
Total, two offerings$4,400,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on BioLite's Form D filed Mar 3, 2025.

JC
Jonathan Cedar
Chief Executive Officer and director
AI
Amar Inamdar
Director
LH
RD
Robb Dahir
Executive officer
DE
Derek Ewald
Executive officer
KH

Sources

  1. SECBioLite, Inc. filing history